vaccines in India, Zydus Cadila has started enrolling and dosing participants for its phase 3 trial to determine the efficacy of its covid-19 shot ZyCov-D, two officials in the know told Mint.“We started enrolment and dosing of participants from Saturday.
The enrolment and dosing happens between 9 am and 5 pm," the principal investigator at one of the sites said.Also Read | Why server stacks are the new realty playZydus Cadila plans to recruit 28,216 volunteers across five sites in four cities, according to information provided to the government’s clinical trial registry.